- The women selected will be randomized into two distinct groups: follow-up/treatment group (FTG) composed of three phases of 8 weeks each or treatment/monitoring group (TFG) consists of two phases of 8 weeks each. The randomization will be through sealed brown envelopes, whose numerical sequence will be generated by computer programming in Statistical Analysis System (SAS), held by a person not participating in the study. Once allocated, all women respond to a clinical and socio-demographic questionnaire, Visual analog scale; Deep Dyspareunia scale; Diagram of Location and characterization of Pain; Endometriosis Health Profile (EHP-30); Female Sexual Function Index pre-and post-treatment. In addition, the woman will fill a daily control of pain. After completing the filling of the instruments will be held a postural evaluation for image capture. The woman will be accompanied by 12 months with regular contact to the review board.